Marinol Capsule
Product Images NDC 53097-570

5 FDA label images from Thepharmanetwork, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Marinol (NDC 53097-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Thepharmanetwork, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Marinol-10mg (Marinol 10mg Cont)

Marinol-10mg (Marinol 10mg Cont)
Label for Marinol (dronabinol) capsules USP, 10 mg strength. The label indicates a package of 60 capsules for oral use. It includes manufacturer and distributor information, dispensing restrictions (Rx Only), and storage instructions. The labeler is ThePharmaNetwork, LLC.*
FDA Label Image

Marinol 2.5 mg 60 Counts Container Label (Marinol 25mg Cont)

Marinol 2.5 mg 60 Counts Container Label (Marinol 25mg Cont)
Marinol 2.5 mg (dronabinol) capsules, USP, packaging label showing a 60 capsule bottle. The label includes dosing strength, manufacturer details (Patheon Softgels Inc., High Point, NC; Akem Laboratories Ltd., Mumbai, India), and distributor information (ThePharmaNetwork, Parsippany, NJ). It contains storage instructions and a barcode.*
FDA Label Image

Marinol-5mg (Marinol 5mg Cont)

Marinol-5mg (Marinol 5mg Cont)
Label for Marinol (dronabinol) capsules, USP, 5 mg strength. The label indicates 60 capsules per container, with NDC 53097-569-60, and states it is a prescription-only oral capsule product. Manufactured by Patheon Softgels Inc. and distributed by ThePharmaNetwork, LLC in Parsippany, New Jersey. The label includes storage instructions and a barcode.*
FDA Label Image

Marinol-graph (Marinol Graph)

Marinol-graph (Marinol Graph)
A line graph titled 'Mean Appetite Change from Baseline' comparing Dronabinol 2.5 mg BID and placebo over 6 weeks. The y-axis shows appetite change in mm VAS, and the x-axis indicates weeks. Dronabinol shows a greater increase in appetite over time compared to placebo, with significant differences at weeks 4 and 6 (p-value <0.05).*
FDA Label Image

Marinol-struct (Marinol Struct)

Marinol-struct (Marinol Struct)
Chemical structure diagram of dronabinol, the active ingredient in Marinol capsules. The structure shows characteristic rings and substituents including hydroxyl and alkyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.